data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Revance Therapeutics
(NASDAQ:RVNC)
15.28
0.15[0.99%]
At close: Jun 24
15.28
00
After Hours: 4:03PM EDT
Day High/Low14.93 - 15.63
52 Week High/Low11.27 - 33.83
Open / Close15.29 / 15.28
Float / Outstanding70.9M / 72.8M
Vol / Avg.1.4M / 766.6K
Mkt Cap1.1B
P/E-
50d Avg. Price14.78
Div / Yield-
Payout Ratio-
EPS-0.94
Total Float70.9M

Revance Therapeutics (NASDAQ:RVNC), Quotes and News Summary

Revance Therapeutics (NASDAQ: RVNC)

Day High/Low14.93 - 15.63
52 Week High/Low11.27 - 33.83
Open / Close15.29 / 15.28
Float / Outstanding70.9M / 72.8M
Vol / Avg.1.4M / 766.6K
Mkt Cap1.1B
P/E-
50d Avg. Price14.78
Div / Yield-
Payout Ratio-
EPS-0.94
Total Float70.9M
Benzinga - May 10, 2022, 4:19PM
Benzinga - Apr 21, 2022, 4:38PM
Benzinga - Apr 21, 2022, 4:06PM
Benzinga - Apr 21, 2022, 4:06PM
Benzinga - Mar 8, 2022, 8:09AM
Benzinga - Feb 28, 2022, 4:26PM
Benzinga - Feb 28, 2022, 4:24PM
Benzinga - Jan 18, 2022, 4:06PM
Benzinga - Jan 7, 2022, 8:08AM
Benzinga - Nov 30, 2021, 6:23AM
Benzinga - Nov 19, 2021, 8:07AM
Benzinga - Nov 9, 2021, 4:52PM
Benzinga - Oct 26, 2021, 8:06AM
Benzinga - Oct 25, 2021, 10:51AM
load more
Sector: Health Care.Industry: Pharmaceuticals
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are Product and the Service Segment. The Products segment generates maximum revenue which is engaged in the research and development of aesthetic and therapeutic products.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-04
REV
Q1 2022Est.ActualSurprise
EPS-0.910-0.940 -0.0300
REV24.010M25.261M1.251M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Revance Therapeutics Questions & Answers

Q
How do I buy Revance Therapeutics (RVNC) stock?
A

You can purchase shares of Revance Therapeutics (NASDAQ: RVNC) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Revance Therapeutics's (RVNC) competitors?
Q
What is the target price for Revance Therapeutics (RVNC) stock?
A

The latest price target for Revance Therapeutics (NASDAQ: RVNC) was reported by Barclays on Tuesday, October 26, 2021. The analyst firm set a price target for 22.00 expecting RVNC to rise to within 12 months (a possible 43.98% upside). 6 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Revance Therapeutics (RVNC)?
A

The stock price for Revance Therapeutics (NASDAQ: RVNC) is $15.28 last updated June 24, 2022, 8:00 PM UTC.

Q
Does Revance Therapeutics (RVNC) pay a dividend?
A

There are no upcoming dividends for Revance Therapeutics.

Q
When is Revance Therapeutics (NASDAQ:RVNC) reporting earnings?
A

Revance Therapeutics’s Q2 earnings are confirmed for Thursday, August 4, 2022.

Q
Is Revance Therapeutics (RVNC) going to split?
A

There is no upcoming split for Revance Therapeutics.

Q
What sector and industry does Revance Therapeutics (RVNC) operate in?
A

Revance Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.